Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Accounts Payables (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Accounts Payables for 16 consecutive years, with $17.3 million as the latest value for Q1 2026.

  • Quarterly Accounts Payables rose 44.05% to $17.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $17.3 million through Jan 2026, up 44.05% year-over-year, with the annual reading at $17.3 million for FY2026, 44.05% up from the prior year.
  • Accounts Payables for Q1 2026 was $17.3 million at Usana Health Sciences, up from $16.2 million in the prior quarter.
  • The five-year high for Accounts Payables was $17.9 million in Q2 2025, with the low at $6.6 million in Q2 2024.
  • Average Accounts Payables over 5 years is $11.5 million, with a median of $10.5 million recorded in 2023.
  • The sharpest move saw Accounts Payables fell 28.31% in 2024, then skyrocketed 169.24% in 2025.
  • Over 5 years, Accounts Payables stood at $11.0 million in 2022, then decreased by 8.86% to $10.1 million in 2023, then rose by 19.01% to $12.0 million in 2024, then surged by 35.34% to $16.2 million in 2025, then increased by 6.44% to $17.3 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $17.3 million, $16.2 million, and $17.9 million for Q1 2026, Q3 2025, and Q2 2025 respectively.